𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune thrombocytopenic purpura and intravenous immunoglobulin

✍ Scribed by Paul Imbach


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
407 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and tolerability of a novel chrom
✍ James B. Bussel; Kim Hanna πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d

The cost of treating immune thrombocytop
✍ Sandler, S. Gerald; Novak, Sharon C.; Roland, Barbara πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 18 KB πŸ‘ 1 views

Multiple factors, including efficacy, toxicity and cost, may influence the decision to treat immune thrombocytopenic purpura (ITP) with intravenous immune globulin (IVIG) or intravenous Rho (D) immune globulin (IV RhIG). We conducted a survey of 50 hospitals in 31 states to determine the costs for t

Thrombotic thrombocytopenic purpura comp
✍ Avani Changela; Kuppuswamy Jagarlamudi; Gina Villani; Meena Alhuwalia; Ashraf El πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 51 KB πŸ‘ 1 views

To the editor: A 60-year-old male was evaluated for episodes of gingival bleed. Past medical history was significant for hypertension currently treated with clonidine and aliskiren and early stage prostate cancer. Social and family histories were noncontributory. Review of systems was negative excep

Immune thrombocytopenic purpura in Hodgk
✍ Kamran Hassidim; Robert McMillan; Michael S. Conjalka; John Morrison πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 316 KB πŸ‘ 2 views

## Abstract Immune thrombocytopenic purpura is rarely seen in Hodgkin disease and the presence of platelet‐associated antibody has not been previously reported in these patients. A patient with Hodgkin disease is described who developed a destructive thrombocytopenia demonstrated by shortened plate